Literature DB >> 24584051

Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors.

Andrea Crotti1, Christopher Benner2, Bilal E Kerman3, David Gosselin1, Clotilde Lagier-Tourenne4, Chiara Zuccato5, Elena Cattaneo5, Fred H Gage3, Don W Cleveland6, Christopher K Glass7.   

Abstract

Huntington's disease (HD) is a fatal neurodegenerative disorder caused by an extended polyglutamine repeat in the N terminus of the Huntingtin protein (HTT). Reactive microglia and elevated cytokine levels are observed in the brains of HD patients, but the extent to which neuroinflammation results from extrinsic or cell-autonomous mechanisms in microglia is unknown. Using genome-wide approaches, we found that expression of mutant Huntingtin (mHTT) in microglia promoted cell-autonomous pro-inflammatory transcriptional activation by increasing the expression and transcriptional activities of the myeloid lineage-determining factors PU.1 and C/EBPs. We observed elevated levels of PU.1 and its target genes in the brains of mouse models and individuals with HD. Moreover, mHTT-expressing microglia exhibited an increased capacity to induce neuronal death ex vivo and in vivo in the presence of sterile inflammation. These findings suggest a cell-autonomous basis for enhanced microglia reactivity that may influence non-cell-autonomous HD pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24584051      PMCID: PMC4113004          DOI: 10.1038/nn.3668

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  54 in total

1.  Pathological cell-cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice.

Authors:  Xiaofeng Gu; Chenjian Li; Weizheng Wei; Victor Lo; Shiaoching Gong; Shi-Hua Li; Takuji Iwasato; Shigeyoshi Itohara; Xiao-Jiang Li; Istvan Mody; Nathaniel Heintz; X William Yang
Journal:  Neuron       Date:  2005-05-05       Impact factor: 17.173

2.  Onset and progression in inherited ALS determined by motor neurons and microglia.

Authors:  Séverine Boillée; Koji Yamanaka; Christian S Lobsiger; Neal G Copeland; Nancy A Jenkins; George Kassiotis; George Kollias; Don W Cleveland
Journal:  Science       Date:  2006-06-02       Impact factor: 47.728

3.  DNA microarray analysis of striatal gene expression in symptomatic transgenic Huntington's mice (R6/2) reveals neuroinflammation and insulin associations.

Authors:  Susan F Crocker; Willard J Costain; Harold A Robertson
Journal:  Brain Res       Date:  2006-04-19       Impact factor: 3.252

Review 4.  How transcription factors program chromatin--lessons from studies of the regulation of myeloid-specific genes.

Authors:  Constanze Bonifer; Maarten Hoogenkamp; Hanna Krysinska; Hiromi Tagoh
Journal:  Semin Immunol       Date:  2008-06-25       Impact factor: 11.130

Review 5.  ALS: a disease of motor neurons and their nonneuronal neighbors.

Authors:  Séverine Boillée; Christine Vande Velde; Don W Cleveland
Journal:  Neuron       Date:  2006-10-05       Impact factor: 17.173

6.  Active and repressive chromatin are interspersed without spreading in an imprinted gene cluster in the mammalian genome.

Authors:  Kakkad Regha; Mathew A Sloane; Ru Huang; Florian M Pauler; Katarzyna E Warczok; Balázs Melikant; Martin Radolf; Joost H A Martens; Gunnar Schotta; Thomas Jenuwein; Denise P Barlow
Journal:  Mol Cell       Date:  2007-08-03       Impact factor: 17.970

7.  Microglial activation in presymptomatic Huntington's disease gene carriers.

Authors:  Yen F Tai; Nicola Pavese; Alexander Gerhard; Sarah J Tabrizi; Roger A Barker; David J Brooks; Paola Piccini
Journal:  Brain       Date:  2007-03-30       Impact factor: 13.501

8.  Microglial activation correlates with severity in Huntington disease: a clinical and PET study.

Authors:  N Pavese; A Gerhard; Y F Tai; A K Ho; F Turkheimer; R A Barker; D J Brooks; P Piccini
Journal:  Neurology       Date:  2006-06-13       Impact factor: 9.910

9.  Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175.

Authors:  Liliana B Menalled; Andrea E Kudwa; Sam Miller; Jon Fitzpatrick; Judy Watson-Johnson; Nicole Keating; Melinda Ruiz; Richard Mushlin; William Alosio; Kristi McConnell; David Connor; Carol Murphy; Steve Oakeshott; Mei Kwan; Jose Beltran; Afshin Ghavami; Dani Brunner; Larry C Park; Sylvie Ramboz; David Howland
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

10.  A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease.

Authors:  Maria Björkqvist; Edward J Wild; Jenny Thiele; Aurelio Silvestroni; Ralph Andre; Nayana Lahiri; Elsa Raibon; Richard V Lee; Caroline L Benn; Denis Soulet; Anna Magnusson; Ben Woodman; Christian Landles; Mahmoud A Pouladi; Michael R Hayden; Azadeh Khalili-Shirazi; Mark W Lowdell; Patrik Brundin; Gillian P Bates; Blair R Leavitt; Thomas Möller; Sarah J Tabrizi
Journal:  J Exp Med       Date:  2008-07-14       Impact factor: 14.307

View more
  134 in total

1.  Increased irritability, anxiety, and immune reactivity in transgenic Huntington's disease monkeys.

Authors:  Jessica Raper; Steven Bosinger; Zachary Johnson; Gregory Tharp; Sean P Moran; Anthony W S Chan
Journal:  Brain Behav Immun       Date:  2016-07-07       Impact factor: 7.217

Review 2.  Microglial priming in Alzheimer's disease.

Authors:  Jun-Wei Li; Yu Zong; Xi-Peng Cao; Lin Tan; Lan Tan
Journal:  Ann Transl Med       Date:  2018-05

Review 3.  Transcriptional and Epigenetic Regulation of Microglia in Health and Disease.

Authors:  Hana Yeh; Tsuneya Ikezu
Journal:  Trends Mol Med       Date:  2018-12-18       Impact factor: 11.951

Review 4.  The choreography of neuroinflammation in Huntington's disease.

Authors:  Andrea Crotti; Christopher K Glass
Journal:  Trends Immunol       Date:  2015-05-20       Impact factor: 16.687

Review 5.  Microglial M1/M2 polarization and metabolic states.

Authors:  Ruben Orihuela; Christopher A McPherson; Gaylia Jean Harry
Journal:  Br J Pharmacol       Date:  2015-05-11       Impact factor: 8.739

Review 6.  Transcriptional control of microglia phenotypes in health and disease.

Authors:  Inge R Holtman; Dylan Skola; Christopher K Glass
Journal:  J Clin Invest       Date:  2017-07-31       Impact factor: 14.808

7.  Gamma frequency entrainment attenuates amyloid load and modifies microglia.

Authors:  Hannah F Iaccarino; Annabelle C Singer; Anthony J Martorell; Andrii Rudenko; Fan Gao; Tyler Z Gillingham; Hansruedi Mathys; Jinsoo Seo; Oleg Kritskiy; Fatema Abdurrob; Chinnakkaruppan Adaikkan; Rebecca G Canter; Richard Rueda; Emery N Brown; Edward S Boyden; Li-Huei Tsai
Journal:  Nature       Date:  2016-12-07       Impact factor: 49.962

8.  HIV-1 gp120 Upregulates Brain-Derived Neurotrophic Factor (BDNF) Expression in BV2 Cells via the Wnt/β-Catenin Signaling Pathway.

Authors:  Yongdi Wang; Jinxu Liao; Shao-Jun Tang; Jianhong Shu; Wenping Zhang
Journal:  J Mol Neurosci       Date:  2017-05-30       Impact factor: 3.444

Review 9.  Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience.

Authors:  Jerome Mertens; Maria C Marchetto; Cedric Bardy; Fred H Gage
Journal:  Nat Rev Neurosci       Date:  2016-05-19       Impact factor: 34.870

Review 10.  The Emerging Roles of Ferroptosis in Huntington's Disease.

Authors:  Yajing Mi; Xingchun Gao; Hao Xu; Yuanyuan Cui; Yuelin Zhang; Xingchun Gou
Journal:  Neuromolecular Med       Date:  2019-01-02       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.